Connect with us

Emerging Markets

Susglobal Energy Corp (OTCMKTS: SNRG) Steady Rise as Co Shares Q1, 2022 Financial Results & Looks to Up List to National Exchange (Leaders in Circular Economy, SusGro)

Published

on

Susglobal Energy Corp (OTCMKTS: SNRG) is an exciting story developing in small caps that is rocketing up the charts recently hitting a high of $0.869 before forming a new base in the $0.70 range. With just 70 million free trading shares in the market and authorized capped at 150 million SNRG has a low float and moves quickly. The Company is NASDAQ bound and needs to get the share price to the $1.25 range to do a 1 for 4 reverse to $5 per share. High value Companies such as SNRG do really well when the reverse onto the NASDAQ. We have written about this phenomenon many times before and SNRG is in great shape here. Speculators are looking for a breakout over $0.869 and its blue skies ahead for SNRG. 

An emerging leader in the circular economy, SNRG is the developer of SusGro™, a revolutionary pathogen-free organic liquid fertilizer and operates a 49-acre Organic & Non-Hazardous Waste Processing & Composting Facility in Belleville, Ontario. SNRG is building out its 51,535 square foot facility on 3.26 acres, in Hamilton, Ontario, which includes an Environmental Compliance Approval (“ECA”) to process up to 65,884 metric tonnes per annum of organic waste into regenerative products as part of the Company’s circular economy model and continued climate change initiatives. Susglobal plans on expanding on its core Canadian operations and use those as a model for processing waste in the United States, beginning with Florida and California by 2024. SusGlobal is also keeping an eye on Europe for possible licensing opportunities. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Susglobal Energy Corp (OTCMKTS: SNRG) is the developer of SusGro™, a revolutionary pathogen-free organic liquid fertilizer and LEADERS IN THE CIRCULAR ECONOMY® are a waste to energy and regenerative products provider and the Company’s resulting fertilizers are available in major home improvement retailers such as Lowe’s Cos. Inc. The Company is an emerging leader in the circular economy; a systems solution framework that tackles global challenges like climate change, biodiversity loss, waste, and pollution. SusGro™, is an award winning and revolutionary pathogen free organic liquid fertilizer, and an industrial, environmental and agricultural biotechnology company focused on acquiring, developing, and monetizing a portfolio of proprietary technologies in the waste to energy and regenerative product applications globally. It is management’s objective to grow SusGlobal into a significant sustainable waste to energy and regenerative products provider and a trusted brand for the fertilizer, soil and aquaculture market, as LEADERS IN THE CIRCULAR ECONOMY®.  

the Company recently signed an Offset Development and Marketing Agreement with Blue Source Canada ULC to develop and market greenhouse gas offset credits from the Company’s 49-acre Organic & Non-Hazardous Waste Processing & Composting Facility in Belleville, Ontario, in order for the Company to monetize and realize benefits from its voluntary activities. This monetization is an exciting development for the Company’s mission to reduce organic wastes from wood, leaf and yard material, treated municipal sewage waste (biosolids), residential curbside green bin material or source separated organics (“SSO”) and paper sludge otherwise destined for landfills, allowing the Company to expand this mission. Bluesource has pioneered creative solutions to climate change for over 20 years. The Company expects to monetize in Q2, 2022. 

On March 14, 2022, the Company announced that its wholly owned subsidiary, SusGlobal Energy Canada Corp. entered into a non-binding letter of intent to acquire a soil media, plant nutrients, and amendments producer approved for organic use and specifically formulated for producing high-quality fruit and flowering crops for an aggregate purchase price of US$15,584,000 (CA$20,000,000). As a condition of the Acquisition, SusGlobal Canada will make a US$3,896,000 (CA$5,000,000) working capital investment into the Target and provided a US$157,018 (CA$200,000) deposit (the “Deposit”) on March 8, 2022. SusGlobal Canada has prepared definitive transaction documents including a Share Purchase Agreement (the “SPA”) for all of the shares of Target. If the closing of the Acquisition does not occur by an agreed upon date in June 2022, the Deposit shall be refunded to SusGlobal Canada. 

Susglobal is building out its new 51,535 square foot facility on 3.26 acres located at 520 Nash Road North, in Hamilton, Ontario, which includes an Environmental Compliance Approval (“ECA”) to process up to 65,884 metric tonnes per annum of organic waste into regenerative products as part of the Company’s circular economy model and continued climate change initiatives. Completion of the second facility is on track and slated for Q3, 2022.. On January 5, 2022, the Company announced that SusGlobal Belleville has received Licence # 2984, at Pt. Lot 20, Conc. 8, Geographic Township of Thurlow, City of Belleville, Hastings County, approved by The Ministry of Northern Development, Mines, Natural Resources and Forestry (“NDMNRF”) to operate a pit above water under Section 18(3)1 of the Aggregate Resources Act (“ARA”) for a 2.66 hectare site with a tonnage condition authorizing removal of 20,000 tonnes of aggregate annually from the site. 

To get an inside look at SNRG Subscribe to Microcapdaily.com immediately by entering your Email below

SNRG

The facility has been designed to produce, distribute and warehouse the Company’s SusGro™ organic liquid fertilizer and other proprietary products that are provided under private label and sold through big box retailers, consumer lawn and garden suppliers and for end use to the wine, cannabis and agriculture industries. The Company believes the Property will be ready to produce and store products by September 30, 2022. With the addition of 11,000 square feet of corporate office space and R&D labs, the Hamilton facility will also house the continued development of SUSGLOBAL’s proprietary formulations, branded liquid and dry organic fertilizers and aquaculture products.

Synthetic chemicals are used extensively to boost yields and to prevent crop loss from pests and fungus. However, overuse of these chemicals is damaging soil health and breeding resistant pests, which is limiting long-term yield potential. SUSGLOBAL is developing technologies to replace existing practices with more environmentally friendly options. 

The Hamilton facility will also house and distribute the products of the recently announced acquisition, a soil media, plant nutrients, and amendments producer, slated to close in Q2 2022. This acquisition is of an International Organization for Standardization (“ISO”) accredited company which only sources the finest inputs in formulating their line of quality products that are sold to customers across Canada and the United States. We have signed a non-binding letter of intent with the ISO accredited company. The ramp up of production and sales of our organic liquid fertilizer and other proprietary products via our Hamilton facility will depend upon the closing of this acquisition. 

On May 24 SNRG announced financial results for the first quarter ended March 31, 2022 and provided an update on its operational progress. Revenue decreased by 25.01% during the first quarter of 2022 to $144,470 compared to the first quarter of 2021 in the amount of $192,660, from decreased business from the Company’s organic waste processing and composting facility. 

Marc Hazout, Executive Chairman, President and CEO of SusGlobal Energy Corp stated: “We continue to process municipal organic waste streams, diverting them from landfills, while producing regenerative products as part of our Circular Economy model. We have confidence in a revenue ramp up this year. Our goal is to complete the acquisition strategy and have our second facility commence the commercialization of our proprietary organic liquid fertilizer in order to increase revenue and cash flow, maximizing shareholder value with an objective to up-list to a major exchange.” 

For More on SNRG Subscribe Right Now!

Currently trading at a $68 million market valuation SNRG has 96,523,547 shares outstanding only 70 million of which are free trading SNRG has a low float and moves fast on any interest. SNRG is an emerging leader in the circular economy and is the developer of SusGro™, an award winning, revolutionary pathogen free organic liquid fertilizer, considered an economical, sustainable and highly effective alternative to traditional fertilizers.  To emphasize SusGlobal’s relatively easy access to feedstock, the Company is banking on what it calls a new “lucrative” contract with a larger municipality which is trying to improve its treatment of organic waste. The contract will reportedly help SusGlobal boost its current operating level from 25% at the Belleville location to close to the facility’s capacity of 120,000 metric tons by the end of 2022. According to new report from Marketsandresearch the future of the organic fertilizer market looks promising with opportunities in the farming and gardening applications. The global organic fertilizer market is expected to reach an estimated $15.8 billion by 2026 with a CAGR of 13.7% from 2020 to 2026. The major drivers for this market are increasing consumption of organic food, favorable government regulations, and ease in availability of organic waste. Microcapdaily first reported on SNRG in the second week of April and we will continue to do so as the Company looks to up list the NASDAQ. We will be updating on SNRG when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with SNRG.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in SNRG either long or short and we have not been compensated for this article.

Continue Reading
2 Comments

2 Comments

  1. truthal

    June 2, 2022 at 10:56 pm

    SNRG has revenue of $0.144 million in Q1 and has experienced more than 25% decrease in revenue for each quarter during 2021 from 2020, but still projects revenue of $14 million for 2022? How can you put such misinformation out? SNRG has not produced even one gallon of liquid fertilizer – the container shown is EMPTY! Check the website – there is no Organic Certification for any or their products. It is illegal to sell organic products without those certifications.

  2. Boe Rimes

    June 4, 2022 at 12:27 am

    Hi Truthal,

    The information was taken from the Company’s own press releases. See here: https://www.otcmarkets.com/stock/SNRG/news/SusGlobal-Energy-Corp-Reports-First-Quarter-2022-Financial-Results?id=358392
    However, I agree with you, based on the Company’s past performance, these projections have no place in the article and we have removed them.
    Boe

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

on

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

on

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Emerging Markets

GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing

Published

on

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12.

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.

So what happened, and what drove the stock to trade 50M shares with filings or news releases?

After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.

With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.

This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.

https://twitter.com/SamanthaLaDuc/status/1657033207412293634?s=20

This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.

To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.

GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.

To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.

By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.

In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.

We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gerd Altmann from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.